semaglutide dailymed (Wegovy) for the Treatment of Obesity Wegovy was approved by the Food and Drug Administration (FDA) in 2021 and is marketed by Novo Nordisk Important Safety Information | GoodGirlRx

Cachexia - an intrinsic factor in wound healing

However, some patients report more pronounced weight loss and improved blood sugar control due to its dual action

B12 shots are very safe with minimal side effects

Currently, the most common types of GLP-1 drugs are semaglutide sold under the brand names Ozempic for type 2 diabetes and Wegovy for weight loss and Just like any medication, GLP-1 drugs have possible side effects and complications

He R, Zheng W, Ginman T, Ottosson H, Norgren S, Zhao Y, et al

Reduced Risk of Obesity-Related Conditions Weight loss can decrease the likelihood of developing conditions such as type 2 diabetes, hypertension, and sleep apnea